These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 38408449)
1. Construction of a Functional Nucleic Acid-Based Artificial Vesicle-Encapsulated Composite Nanoparticle and Its Application in Retinoblastoma-Targeted Theranostics. Hu X; Zhang D; Huang L; Zeng Z; Su Y; Chen S; Lin X; Hong S ACS Biomater Sci Eng; 2024 Mar; 10(3):1830-1842. PubMed ID: 38408449 [TBL] [Abstract][Full Text] [Related]
2. A Smart, Autocatalytic, DNAzyme Biocircuit for in Vivo, Amplified, MicroRNA Imaging. Wei J; Wang H; Wu Q; Gong X; Ma K; Liu X; Wang F Angew Chem Int Ed Engl; 2020 Apr; 59(15):5965-5971. PubMed ID: 31961985 [TBL] [Abstract][Full Text] [Related]
3. Dual-Target Multifunctional Superparamagnetic Cationic Nanoliposomes for Multimodal Imaging-Guided Synergistic Photothermal/Photodynamic Therapy of Retinoblastoma. Zheng W; Li X; Zou H; Xu Y; Li P; Zhou X; Wu M Int J Nanomedicine; 2022; 17():3217-3237. PubMed ID: 35924259 [TBL] [Abstract][Full Text] [Related]
4. A laser-activated multifunctional targeted nanoagent for imaging and gene therapy in a mouse xenograft model with retinoblastoma Y79 cells. Wu M; Xiong H; Zou H; Li M; Li P; Zhou Y; Xu Y; Jian J; Liu F; Zhao H; Wang Z; Zhou X Acta Biomater; 2018 Apr; 70():211-226. PubMed ID: 29452275 [TBL] [Abstract][Full Text] [Related]
5. Nanoparticle-mediated gene therapy as a novel strategy for the treatment of retinoblastoma. Mandal M; Banerjee I; Mandal M Colloids Surf B Biointerfaces; 2022 Dec; 220():112899. PubMed ID: 36252537 [TBL] [Abstract][Full Text] [Related]
6. An anti-GD2 aptamer-based bifunctional spherical nucleic acid nanoplatform for synergistic therapy targeting MDM2 for retinoblastoma. Wang S; Zhao Y; Yao F; Wei P; Ma L; Zhang S Biomed Pharmacother; 2024 May; 174():116437. PubMed ID: 38522240 [TBL] [Abstract][Full Text] [Related]
7. MRI-guided dual-responsive anti-tumor nanostructures for synergistic chemo-photothermal therapy and chemodynamic therapy. Shi Y; Zhou M; Zhang Y; Wang Y; Cheng J Acta Biomater; 2023 Mar; 158():571-582. PubMed ID: 36586501 [TBL] [Abstract][Full Text] [Related]
8. Dual biomarkers-activatable hollow MnO Ning J; Hu G; Wu T; Zhao Y; Nie Y; Zhou Y Anal Chim Acta; 2024 May; 1303():342521. PubMed ID: 38609263 [TBL] [Abstract][Full Text] [Related]
10. The functional role of circular RNAs in the pathogenesis of retinoblastoma: a new potential biomarker and therapeutic target? Karami Fath M; Pourbagher Benam S; Kouhi Esfahani N; Shahkarami N; Shafa S; Bagheri H; Shafagh SG; Payandeh Z; Barati G Clin Transl Oncol; 2023 Aug; 25(8):2350-2364. PubMed ID: 37000290 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional Nanoparticles for Multimodal Imaging-Guided Low-Intensity Focused Ultrasound/Immunosynergistic Retinoblastoma Therapy. Wang M; Yang Q; Li M; Zou H; Wang Z; Ran H; Zheng Y; Jian J; Zhou Y; Luo Y; Ran Y; Jiang S; Zhou X ACS Appl Mater Interfaces; 2020 Feb; 12(5):5642-5657. PubMed ID: 31940169 [TBL] [Abstract][Full Text] [Related]
13. The Use of rAAV2-RB1-Mediated Gene Therapy in Retinoblastoma. Shi H; He X; Yang Z; Liao Q; Ruan J; Ge S; Chai P; Jia R; Fan J; Wen X; Fan X Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):31. PubMed ID: 38133505 [TBL] [Abstract][Full Text] [Related]
14. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model. Wang H; Wei F; Li H; Ji X; Li S; Chen X Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955 [TBL] [Abstract][Full Text] [Related]
15. Dissecting the Transcriptional and Chromatin Accessibility Heterogeneity of Proliferating Cone Precursors in Human Retinoblastoma Tumors by Single Cell Sequencing-Opening Pathways to New Therapeutic Strategies? Collin J; Queen R; Zerti D; Steel DH; Bowen C; Parulekar M; Lako M Invest Ophthalmol Vis Sci; 2021 May; 62(6):18. PubMed ID: 34003213 [TBL] [Abstract][Full Text] [Related]
16. Tumor microenvironment-responsive versatile "Trojan horse" theranostic nanoplatform for magnetic resonance imaging-guided multimodal synergistic antitumor treatment. Huang Q; Pan Y; Wang M; Liu Z; Chen H; Wang J; Zhao Z; Zhang Y Acta Biomater; 2022 Jul; 147():270-286. PubMed ID: 35595202 [TBL] [Abstract][Full Text] [Related]
17. Psychosocial determinants for treatment decisions in familial retinoblastoma. Soliman SE; Ulster A; MacDonald H; VandenHoven C; Toi A; Hèon E; Gallie B Ophthalmic Genet; 2017; 38(4):392-394. PubMed ID: 28085520 [No Abstract] [Full Text] [Related]
18. A DNAzyme dual-feedback autocatalytic exponential amplification biocircuit for microRNA imaging in living cells. Huang X; Li Z; Shi Y; Zhang Y; Shen T; Chen M; Huang Z; Tong Y; Liu SY; Guo J; Zou X; Dai Z Biosens Bioelectron; 2023 Dec; 241():115669. PubMed ID: 37688849 [TBL] [Abstract][Full Text] [Related]
19. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma. Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867 [TBL] [Abstract][Full Text] [Related]
20. Next-Generation Technologies and Strategies for the Management of Retinoblastoma. Gudiseva HV; Berry JL; Polski A; Tummina SJ; O'Brien JM Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]